BOTHELL, Wash., Jan. 2 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (NASDAQ:CSCX), a global leader in advanced cardiac monitoring and defibrillation products, announced today that it will present at the 10th Annual Needham & Company, LLC Growth Conference at the New York Palace Hotel on Tuesday, January 8, 2008, at 1:30 p.m. Eastern Time. Michael Matysik, senior vice president and chief financial officer, will review the Company's business strategy and recent financial results.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO) Attendance at the conference is by invitation only. Cardiac Science will offer a live audio webcast of its presentation, which may be accessed at the Company's website at http://www.cardiacscience.com/. An archived replay of the presentation will also be available following the live presentation and can be accessed at http://www.cardiacscience.com/ for 90 days.
About Cardiac Science Corporation Cardiac Science is truly at the heart of saving lives. The Company develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor - defibrillators and cardiology data management systems. Cardiac Science also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services. The Company is the successor to various entities that have owned and operated cardiology-related businesses that sold products under the trusted brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science is headquartered in Bothell, WA, and also has operations in California and Wisconsin, China, Denmark, France and the United Kingdom.
Company Contact:
Mike Matysik
Cardiac Science Corporation
Chief Financial Officer
425-402-2206 Investor Contact:
EVC Group, Inc. Douglas Sherk/Jenifer Kirtland
415-896-6820 Media Contact:
EVC Group, Inc. Steve DiMattia
646-277-8706
http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO http://photoarchive.ap.org/ DATASOURCE: Cardiac Science Corporation CONTACT: Company, Mike Matysik, Chief Financial Officer of Cardiac Science Corporation, +1-425-402-2206; or Investors, Douglas Sherk, or Jenifer Kirtland, +1-415-896-6820, or Media, Steve DiMattia, +1-646-277-8706, all of EVC Group, Inc. for Cardiac Science Corporation Web site: http://www.cardiacscience.com/
|